Clinically undetected malignancies in deceased organ and tissue donors: solid organ recipient outcomes and cryopreserved tissue discard

Introduction Unexpected donor malignancy creates uncertainty for solid organ recipients and affects tissue release decisions. Methods We retrospectively reviewed two tissue donor cohorts in Czechia during 2021–2025: 78 vascular and 57 musculoskeletal donors, with one donor contributing to both cohorts, giving 134 unique donors. Results and Discussion Malignancy was identified in 1/78 vascular donors (1.28%; pancreatic adenocarcinoma) and 3/57 musculoskeletal donors (5.26%; two prostate adenocarcinomas and one papillary thyroid carcinoma). Pancreatic cancer was diagnosed on definitive sections from an intraoperative biopsy; the other cancers were identified at autopsy. Three affected donors provided six kidneys and one liver to seven recipients. Transplant-center reports of routine clinical follow-up documented no donor-transmitted malignancy during 14–39 months of available follow-up. Six recipients were alive with functioning grafts; one kidney recipient died from sepsis at 14 months. No tissue from the four affected donors was released for clinical use: 14 processed grafts and 19 unprocessed tissue collections were discarded. Histopathology detected the donor cancers; quarantine and final release checks within the quality management system (QMS) prevented tissue release in all four cases. These observations do not establish equivalent transmission risks across tumor types, exclude later transmission, or quantify the sensitivity or overall effectiveness of the QMS.

Authors

Institutions

Publication Details

Journal
Frontiers in Transplantation
Published
2026-11-13
DOI
https://doi.org/10.3389/frtra.2026.1977326
Primary Topic
Organ Donation and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinically undetected malignancies in deceased organ and tissue donors: solid organ recipient outcomes and cryopreserved tissue discard

Miroslava Jandová, Igor Guňka, L Janoušek, Jiří Gregor et al.
1 links
Frontiers in Transplantation
Organ Donation and Transplantation
article

Clinically undetected malignancies in deceased organ and tissue donors: solid organ recipient outcomes and cryopreserved tissue discard

Miroslava Jandová, Igor Guňka, L Janoušek, Jiří Gregor, Miroslav Podhola, Miroslav Špaček, Pavel Měřička, P Navrátil, Roman Keleman, Tomas Holecek
article en

Abstract

Introduction Unexpected donor malignancy creates uncertainty for solid organ recipients and affects tissue release decisions. Methods We retrospectively reviewed two tissue donor cohorts in Czechia during 2021–2025: 78 vascular and 57 musculoskeletal donors, with one donor contributing to both cohorts, giving 134 unique donors. Results and Discussion Malignancy was identified in 1/78 vascular donors (1.28%; pancreatic adenocarcinoma) and 3/57 musculoskeletal donors (5.26%; two prostate adenocarcinomas and one papillary thyroid carcinoma). Pancreatic cancer was diagnosed on definitive sections from an intraoperative biopsy; the other cancers were identified at autopsy. Three affected donors provided six kidneys and one liver to seven recipients. Transplant-center reports of routine clinical follow-up documented no donor-transmitted malignancy during 14–39 months of available follow-up. Six recipients were alive with functioning grafts; one kidney recipient died from sepsis at 14 months. No tissue from the four affected donors was released for clinical use: 14 processed grafts and 19 unprocessed tissue collections were discarded. Histopathology detected the donor cancers; quarantine and final release checks within the quality management system (QMS) prevented tissue release in all four cases. These observations do not establish equivalent transmission risks across tumor types, exclude later transmission, or quantify the sensitivity or overall effectiveness of the QMS.

Frontiers in TransplantationVol. 5
Charles University (CZ), Institute of Clinical and Experimental Medicine (CZ), University Hospital Hradec Králové (CZ)
Good health and well-being
Organ Donation and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon